In particular, factors that have already proven their usefulness in related clinical settings of endothelial dysfunction are of interest, such as the modulation of vascular endothelial growth factor (VEGF) levels in patients with renal failure undergoing hemodialysis (HD) or peritoneal dialysis (PD) [8,15]. This evidence concerns the gene VEGFA and Renal insufficiency.